You must have Credits on your Balance to download this sample
pharmacotherapeutics for prescribing
Pages 12 (3012 words)
Pharmacotherapeutics of Metoclopramide and Co-danthramer drugs Name: University: Course: Date: Introduction The major aim of this paper was to explore various aspects related to the Pharmacotherapeutics of Metoclopramide 10mg and co-danthramer drugs on the patient with nausea and constipation as well as with gastric cancer…
Vomiting is the forcible involuntary or voluntary stomach contents emptying ("throwing up") through the mouth (Schnell F, 2003) .However vomiting, nausea and constipation might be as a result of gastric cancer related complications that the patient had. To really understand how this condition of the patient can be managed or treated, the Pharmacotherapeutics of these two suggested drugs has been discussed in detail. Metoclopramide 10mg is used in the treatment of vomiting, Digestive disorders, Nausea and Migraine. Metoclopramide increases the muscles contractions or movements in the intestines and stomach (Schnell F. 2003). These results to a decrease in the duration the stomach contents take to move through the digestive tract. On the other hand, Co-danthramer suspension and capsules have 2 active ingredients, Poloxamer 188 and Dantron. Both of these drugs are referred to as laxatives. Hence in combination it is called co-danthramer. Dantron is laxative type referred to as stimulant laxative. It acts by nerve endings stimulation in the intestines walls. This results to intestinal wall muscles to contract frequently with increased force. The gut’s contents are moved along the intestines as a result of these muscles contraction, hence relieving constipation. Poloxamer 188 is referred to as faecal softener. ...
Not exactly what you need?